"A 232% growth in sales for H1 maintains our 8-year growth trend and takes our CY20 revenue to in excess of $6m with cash on hand increased $0.8m for the year to $2.3m. Building a real value asset requires sales, and these results demonstrate the strength of our expanding distribution network with both Uscom China and Uscom Europe returning profit in H1. While continuing to strongly grow fundamentals and accumulate cash, we have invested in the expansion of international operations, established new subsidiaries and finalised multiple international regulatory approvals. These results validate our strategy as we build the foundations for rapid revenue growth and increasing shareholder value as the cascade of new regulatory approvals for China, Europe and the US are achieved over the next year. Although international markets remain unpredictable, we are optimistic that our new international approvals will generate continued growth as our new products are fed into expanding international distribution network."
Prof. Rob Phillips